CD44 and neoplasm: Consistent with this finding, the abundances of tumor stem/progenitor cells, CD44+ cells, Sox9+ cells, and CD133+ cells, were markedly decreased in colon tumors from Prrc2a‐deficient mice (Figure 2C).